William K McVicar

Statistics

Publications

Citations

H-Index

Active since

2008

Affiliations

Inotek Pharmaceuticals (United States)(Current)

William K McVicar is an author at Inotek Pharmaceuticals (United States) specializing in pharmacotherapy, clinical pharmacology, and pharmacodynamics.

Publications per year

2008–2016

Publications

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma

Jonathan S. Myers, Kenneth Sall, Harvey Dubiner et al. · Journal of Ocular Pharmacology and Therapeutics · 2016 · 56 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers

Alan M. Laties, Cadmus Rich, R Stoltz et al. · Journal of Ocular Pharmacology and Therapeutics · 2016 · 21 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects

Kenneth Tripp, William K McVicar, Parameswaran Nair et al. · Journal of Allergy and Clinical Immunology · 2008 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

1–3 of 3